Condition: Lymphoma · Sponsor: Hoffmann-La Roche
The purpose of the study is to evaluate glofitamab + gemcitabine + oxaliplatin in participants in the United States, including under-represented racial and ethnic populations, that have relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
This description comes directly from the study's public registry record.
Reference Study ID Number: GO44900 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| UC San Diego Moores Cancer Center | La Jolla, California, United States | Recruiting |
| Saddleback Memorial Medical Center | Laguna Hills, California, United States | Recruiting |
| Hoag Memorial Hospital | Newport Beach, California, United States | Recruiting |
| University of California Los Angeles (UCLA) - Cancer Care - Santa Monica | Santa Monica, California, United States | Recruiting |
| Georgetown University | Washington D.C., District of Columbia, United States | Recruiting |
| AdventHealth Cancer Institute | Orlando, Florida, United States | Recruiting |
| Winship Cancer Institute of Emory University | Atlanta, Georgia, United States | Recruiting |
| University of Illinois Cancer Center | Chicago, Illinois, United States | Recruiting |
| Kansas City VA Medical Center | Kansas City, Kansas, United States | Recruiting |
| Walter Reed National Military Medical Center | Bethesda, Maryland, United States | Recruiting |
| Christus Health - Christus St. Vincent Regional Medical Center | Santa Fe, New Mexico, United States | Recruiting |
| Stony Brook Univ Cancer Ctr | Stony Brook, New York, United States | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06624085